Clinical Trials
3 trialsNCT00159484 2017-06-27
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
University of Southern California
Phase 1/2 Unknown
NCT00171834 2014-02-05
Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer
Novartis
Phase 1/2 Completed
NCT00715013 2011-09-15
Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
University of Zurich
Phase 1/2 Completed